HGBCL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma (NCT07249905) | ModeX Therapeutics, An OPKO Health Company | 2026-04-13 |
Track HGBCL automatically
Every clearance here is in the API, with alerts when new ones post.